Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EUDA

Euda Health Holdings Limited

Jun 01 • 11:51AM ET

17.08

-0.98 -5.43 %

Real Estate • Real Estate Services • Singapore • Nano • NASD

Today, 6:10 AMEUDA Health launches Regenixé iPSC-derived Skin Stem Cell Secretome Mask under exclusive global distributorship rights

Peers: ASPS DUO MAYS RFL STHO DOUG SRG CHCI NEN MMI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	37.59%	Shs Outstand	24.78M	Perf Week	-1.61%
Market Cap	42.53M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.56M	Perf Month	17.55%
Enterprise Value	44.57M	PEG	-	EPS next Q	0.40	Inst Own	0.04%	Short Float	1.31%	Perf Quarter	-2.11%
Income	-2.77M	P/S	6.24	EPS this Y	900.00%	Inst Trans	-32.48%	Short Ratio	0.17	Perf Half Y	-70.30%
Sales	6.82M	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.02M	Perf YTD	-63.03%
Book/sh	-2.25	P/C	121.51	EPS next 5Y	-	ROE	-	52W High	86.00 -80.14%	Perf Year	-76.60%
Cash/sh	0.14	P/FCF	-	EPS past 3/5Y	67.02% -	ROIC	-	52W Low	5.26 224.71%	Perf 3Y	-39.43%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-11.50% -10.32%	Gross Margin	43.88%	Volatility	3.59% 13.08%	Perf 5Y	-
Dividend TTM	-	EV/Sales	6.54	EPS Y/Y TTM	86.20%	Oper. Margin	-35.78%	ATR (14)	1.82	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.18	Sales Y/Y TTM	-	Profit Margin	-40.65%	RSI (14)	59.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.18	EPS Q/Q	-563.66%	SMA20	7.00%	Beta	0.64	Target Price	55.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	43.99%	Rel Volume	0.19	Prev Close	18.06
Employees	123	LT Debt/Eq	-	Earnings	Feb 25	SMA200	-47.20%	Avg Volume	118.10K	Price	17.08
IPO	Dec 14, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	9,407	Change	-5.43%

Today 06:05AM	EUDA Health Expands Helixe Product Line with Launch of Regenixe iPSC-Derived Skin Stem Cell Secretome Mask (GlobeNewswire) -5.43%
06:00AM	EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
Apr-28-26 06:00AM	EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development (GlobeNewswire) -6.69%
Apr-27-26 06:00AM	EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities (GlobeNewswire) +21.09%
Mar-19-26 05:30AM	EUDA Announces Reverse Stock Split of its Ordinary Shares (GlobeNewswire) -15.19%
09:10AM	Loading…
Mar-04-26 09:10AM	EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant (GlobeNewswire)
Jan-15-26 08:59AM	EUDA Health Announces Second Amendment to Streeterville Warrant Agreement (GlobeNewswire)
Jan-13-26 07:49AM	EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform (GlobeNewswire) -13.93%
Jan-07-26 06:00AM	EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement (GlobeNewswire) +5.70%
Dec-30-25 07:00AM	EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital (GlobeNewswire)
Dec-29-25 07:00AM	EUDA Health to Launch EUDA Helixe 2.0 in January 2026 (GlobeNewswire)
Dec-23-25 07:00AM	EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen (GlobeNewswire) +41.18%
Dec-22-25 07:00AM	EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem (GlobeNewswire) -51.43%
Dec-08-25 07:00AM	EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem (GlobeNewswire) +8.46%
Dec-05-25 09:30AM	EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement (GlobeNewswire) -6.21%
09:00AM	Loading…
Oct-23-25 09:00AM	EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India (GlobeNewswire) -15.49%
Oct-20-25 09:00AM	EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia (GlobeNewswire)
Sep-10-25 09:30AM	EUDA Signs Letter of Intent to Potentially Acquire GO POSB (GlobeNewswire) -5.44%
Sep-04-25 08:00AM	EUDA Strategically Expands into T-Cell Immunotherapy - Strengthening Its Stem Cell Therapy Portfolio (GlobeNewswire) -9.09%
Aug-28-25 08:00AM	EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd (GlobeNewswire)
Aug-26-25 08:00AM	EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement (GlobeNewswire) -15.73%
Apr-24-25 07:00AM	EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia (GlobeNewswire)
Dec-16-24 05:00PM	EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation (GlobeNewswire) -7.37%
Oct-31-24 07:00AM	NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule (GlobeNewswire) -5.97%
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Sep-19-24 08:00AM	Diamond Equity Research Initiates Coverage on EUDA Health Holdings Limited (NASDAQ:EUDA) (GlobeNewswire) -5.77%
Aug-21-24 07:00AM	Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now (GlobeNewswire) +6.55%
Aug-20-24 07:00AM	Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now (GlobeNewswire)
May-08-24 08:44AM	EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia (GlobeNewswire) +12.57%
05:00PM	Loading…
May-06-24 05:00PM	EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health (GlobeNewswire) +5.59% -7.41%
Jan-16-24 06:15PM	EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Markets Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire) -5.03%
05:29PM	EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
Oct-05-23 09:00AM	EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc. (GlobeNewswire) +7.74%
Sep-22-23 08:00AM	EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Markets Continued Listing Requirements (GlobeNewswire)
Aug-14-23 08:15AM	EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement (GlobeNewswire)
Aug-04-23 08:30AM	EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
May-19-23 04:05PM	EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter (PR Newswire)
Apr-10-23 04:15PM	EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter (PR Newswire) -6.62%
Mar-14-23 07:08AM	EUDA Health Holdings (NASDAQ:EUDA) shareholders are up 42% this past week, but still in the red over the last year (Simply Wall St.)
Nov-23-22 04:32PM	8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination (GlobeNewswire) -15.09% +37.04%

8i Acquisition 2 Corp. is a blank check company. Its purpose is to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 21, 2021 and is headquartered in Singapore.

Chief Technology OfficerMr. Daniel Tan

CEO & Executive DirectorMr. Alfred Lim

Interim Chief Financial OfficerMs. Whye Shin Tay

Operational DirectorMr. Aaron Lim

Chief Executive Officer of CK Health PlusMr. Alex Lai

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EUDA

Euda Health Holdings Limited

Upgrade your Finviz experience